How Long to Read Considering the Patient in Pediatric Drug Development

How Long Does it Take to Read Considering the Patient in Pediatric Drug Development?

It takes the average reader 7 hours and 5 minutes to read Considering the Patient in Pediatric Drug Development by Klaus Rose

Assuming a reading speed of 250 words per minute. Learn more

Description

Considering the Patient in Pediatric Drug Development: How Good Intentions Turned into Harm addresses a fundamental challenge in drug development and healthcare for young patients. In clinical trials and clinical practice, the term "children" is used ambiguously to confer physiological characteristics to a chronological age limit, which in reality does not exist. This book outlines why the United States (US) and European Union's (EU) regulatory authorities, pediatric academia, and the pharmaceutical industry demand, support and perform pediatric drug studies, along with the key flaws of this demand that blurs the different administrative and physiological meanings of the term "child." In addition, the book covers why most pediatric regulatory studies lack medical sense and many even harm young patients and the conflicts of interest behind pediatric drug studies. It includes relevant information about the maturation of the human body regarding absorption, distribution, metabolism and excretion of food and drugs as well as key differences between newborns, infants, older children and adolescents. Explains relevant information about the maturation of the human body regarding absorption, distribution, metabolism and excretion of food and drugs, including key differences between newborns, infants, older children and adolescents Discusses historical roots of separate drug approval in officially labeled "children" and conflicts of interest in performing and publishing "pediatric" research Helps to decipher justifications for pediatric studies to help people navigate the relevance of the information

How long is Considering the Patient in Pediatric Drug Development?

Considering the Patient in Pediatric Drug Development by Klaus Rose is 416 pages long, and a total of 106,496 words.

This makes it 140% the length of the average book. It also has 130% more words than the average book.

How Long Does it Take to Read Considering the Patient in Pediatric Drug Development Aloud?

The average oral reading speed is 183 words per minute. This means it takes 9 hours and 41 minutes to read Considering the Patient in Pediatric Drug Development aloud.

What Reading Level is Considering the Patient in Pediatric Drug Development?

Considering the Patient in Pediatric Drug Development is suitable for students ages 12 and up.

Note that there may be other factors that effect this rating besides length that are not factored in on this page. This may include things like complex language or sensitive topics not suitable for students of certain ages.

When deciding what to show young students always use your best judgement and consult a professional.

Where Can I Buy Considering the Patient in Pediatric Drug Development?

Considering the Patient in Pediatric Drug Development by Klaus Rose is sold by several retailers and bookshops. However, Read Time works with Amazon to provide an easier way to purchase books.

To buy Considering the Patient in Pediatric Drug Development by Klaus Rose on Amazon click the button below.